S&P 500 7,429.58 ▲ 35.28 (+0.48%) DOW 51,187.74 ▲ 338.99 (+0.67%) NASDAQ 25,887.75 ▲ 78.09 (+0.30%) US Markets Closed â€ĸ 04:47 AM ET

ARAY

Accuray Incorporated

Price Chart
Latest Quote

$0.34

+0.01 (+2.41%)
Current Price
Previous Close $0.33
Open $0.33
Day High $0.35
Day Low $0.31
Volume 1,064,370
Fetched: 2026-06-12T02:41:17
Stock Information
Shares Outstanding 118.96M
Total Debt $182.40M
Cash Equivalents $38.07M
Revenue $428.57M
Net Income $-46.13M
Sector Healthcare
Industry Medical Devices
Market Cap $40.60M
EPS (TTM) $-0.38
Exchange NMS
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$184.93M
Sales$428.57M
Income$-46.13M
Book/sh$0.35
Cash/sh$0.32
Employees990
Financial Ratios
Quick Ratio0.58
Current Ratio1.42
Debt/Eq437.33
Returns & Margins
ROA-1.65%
ROE-101.06%
Gross Margin26.92%
Operating Margin-2.43%
Profit Margin-10.76%
Ownership
Insider Ownership4.35%
Institutional Ownership69.15%
Insider & Institutional transactions data not available
Valuation Ratios
Forward P/E-1.42
PEG29.49
P/S0.09
P/B0.97
Analyst Data
Recommendationnone
Target Price$0.35
Technical Indicators
SMA20$0.35
SMA50$0.38
SMA200$0.88
RSI55.56
ATR0.0450
Shares Float113.04M
Short Float7.81%
Short Ratio1.63
Volatility1.35
Rel Volume0.21
Performance History
Week+0.00%
Month+13.33%
Quarter-8.11%
6 Months-68.52%
YTD-60.00%
Year-72.80%
3 Years-90.68%
5 Years-92.18%
10 Years-93.40%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-12 $0.34 1,439,900
2026-06-11 $0.34 1,103,700
2026-06-10 $0.33 1,197,200
2026-06-09 $0.33 1,417,300
2026-06-08 $0.35 1,311,900
2026-06-05 $0.34 3,680,200
2026-06-04 $0.37 1,522,300
2026-06-03 $0.37 1,221,100
2026-06-02 $0.40 1,786,600
2026-06-01 $0.39 3,568,200
2026-05-29 $0.38 4,899,900
2026-05-28 $0.42 5,530,700
2026-05-27 $0.39 17,359,500
2026-05-26 $0.37 17,488,000
2026-05-22 $0.31 3,862,600
2026-05-21 $0.31 2,417,300
2026-05-20 $0.33 7,199,000
2026-05-19 $0.29 4,324,400
2026-05-18 $0.29 17,692,700
2026-05-15 $0.27 38,320,200
2026-05-14 $0.28 3,465,700
2026-05-13 $0.30 2,591,200
About Accuray Incorporated

Accuray Incorporated engages in the design, development, manufacture, and sale of radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. It also provides the TomoTherapy platform, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, the company offers post-contract customer support, installation, training, and other professional services. It primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Period:
Loading...
Income Statement (Annual)
Metric 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Revenue
Reconciled Cost Of Revenue $311,538,000 $303,630,000 $293,645,000 $269,954,000
Cost Of Revenue $311,538,000 $303,630,000 $293,645,000 $269,954,000
Total Revenue $458,505,000 $446,551,000 $447,605,000 $429,909,000
Operating Revenue $458,505,000 $446,551,000 $447,605,000 $429,909,000
Expenses
Interest Expense $12,954,000 $11,624,000 $10,632,000 $8,129,000
Total Expenses $450,666,000 $446,047,000 $445,223,000 $421,761,000
Other Income Expense $5,057,000 $-1,931,000 $1,462,000 $-2,021,000
Other Non Operating Income Expenses $170,000 $88,000 $-232,000 $356,000
Net Non Operating Interest Income Expense $-11,762,000 $-10,393,000 $-10,632,000 $-8,129,000
Interest Expense Non Operating $12,954,000 $11,624,000 $10,632,000 $8,129,000
Operating Expense $139,128,000 $142,417,000 $151,578,000 $151,807,000
Selling And Marketing Expense $43,315,000 $42,619,000 $46,178,000 $49,664,000
General And Administrative Expense $47,871,000 $50,066,000 $48,271,000 $44,391,000
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-1,591,000 $-15,545,000 $-9,280,000 $-5,347,000
Net Interest Income $-11,762,000 $-10,393,000 $-10,632,000 $-8,129,000
Interest Income $1,192,000 $1,231,000 - -
Normalized Income $-1,727,670 $-12,497,970 $-8,586,380 $-3,278,780
Net Income From Continuing And Discontinued Operation $-1,591,000 $-15,545,000 $-9,280,000 $-5,347,000
Total Operating Income As Reported $7,839,000 $504,000 $2,382,000 $8,148,000
Net Income Common Stockholders $-1,591,000 $-15,545,000 $-9,280,000 $-5,347,000
Net Income $-1,591,000 $-15,545,000 $-9,280,000 $-5,347,000
Net Income Including Noncontrolling Interests $-1,591,000 $-15,545,000 $-9,280,000 $-5,347,000
Net Income Continuous Operations $-1,591,000 $-15,545,000 $-9,280,000 $-5,347,000
Pretax Income $1,134,000 $-11,820,000 $-6,788,000 $-2,002,000
Special Income Charges $1,475,000 $0 $0 $0
Earnings From Equity Interest $4,714,000 $1,838,000 $2,572,000 $241,000
Interest Income Non Operating $1,192,000 $1,231,000 - -
Operating Income $7,839,000 $504,000 $2,382,000 $8,148,000
Gross Profit $146,967,000 $142,921,000 $153,960,000 $159,955,000
Per Share
Diluted EPS $-0.02 $-0.16 $-0.10 $-0.06
Basic EPS $-0.02 $-0.16 $-0.10 $-0.06
Other
Tax Effect Of Unusual Items $36,330 $-809,970 $-184,380 $-549,780
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $20,065,000 $9,566,000 $9,249,000 $14,258,000
Total Unusual Items $173,000 $-3,857,000 $-878,000 $-2,618,000
Total Unusual Items Excluding Goodwill $173,000 $-3,857,000 $-878,000 $-2,618,000
Reconciled Depreciation $6,150,000 $5,905,000 $4,527,000 $5,513,000
EBITDA (Bullshit earnings) $20,238,000 $5,709,000 $8,371,000 $11,640,000
EBIT $14,088,000 $-196,000 $3,844,000 $6,127,000
Diluted Average Shares $102,768,000 $98,272,000 $94,884,000 $92,095,000
Basic Average Shares $102,768,000 $98,272,000 $94,884,000 $92,095,000
Diluted NI Availto Com Stockholders $-1,591,000 $-15,545,000 $-9,280,000 $-5,347,000
Tax Provision $2,725,000 $3,725,000 $2,492,000 $3,345,000
Other Special Charges $-1,475,000 - - -
Gain On Sale Of Security $-1,302,000 $-3,857,000 $-878,000 $-2,618,000
Research And Development $47,942,000 $49,732,000 $57,129,000 $57,752,000
Selling General And Administration $91,186,000 $92,685,000 $94,449,000 $94,055,000
Other Gand A $47,871,000 $50,066,000 $48,271,000 $44,391,000
Fetched: 2026-06-08
Balance Sheet (Annual)
Metric 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Assets
Net Tangible Assets $23,352,000 $-12,647,000 $-4,232,000 $-4,901,000
Total Assets $470,239,000 $468,627,000 $479,214,000 $472,849,000
Total Non Current Assets $152,774,000 $145,391,000 $141,181,000 $121,959,000
Other Non Current Assets $18,680,000 $8,001,000 $6,545,000 $5,452,000
Non Current Deferred Assets $6,115,000 $8,427,000 $10,104,000 $9,754,000
Non Current Deferred Taxes Assets $756,000 $659,000 $860,000 -
Non Current Accounts Receivable $3,777,000 $2,859,000 $4,734,000 $5,301,000
Goodwill And Other Intangible Assets $57,817,000 $57,731,000 $57,891,000 $58,090,000
Other Intangible Assets $15,000 $59,000 $210,000 $250,000
Current Assets $317,465,000 $323,236,000 $338,033,000 $350,890,000
Other Current Assets $6,929,000 $3,970,000 $1,683,000 $3,573,000
Current Deferred Assets $3,711,000 $2,726,000 $2,350,000 $3,049,000
Restricted Cash $574,000 $485,000 $524,000 $204,000
Prepaid Assets $9,948,000 $10,306,000 $11,629,000 $11,573,000
Inventory $141,020,000 $138,324,000 $145,150,000 $142,254,000
Receivables $97,867,000 $98,855,000 $87,295,000 $101,500,000
Other Receivables $2,453,000 $2,460,000 - $13,325,000
Taxes Receivable $12,222,000 $4,394,000 $12,518,000 $7,058,000
Accounts Receivable $83,192,000 $92,001,000 $74,777,000 $94,442,000
Allowance For Doubtful Accounts Receivable $-369,000 $-2,251,000 $-3,079,000 $-1,000,000
Gross Accounts Receivable $83,561,000 $94,252,000 $77,856,000 $95,442,000
Cash Cash Equivalents And Short Term Investments $57,416,000 $68,570,000 $89,402,000 $88,737,000
Cash And Cash Equivalents $57,416,000 $68,570,000 $89,402,000 $88,737,000
Debt
Net Debt $79,104,000 $103,586,000 $87,881,000 $91,733,000
Total Debt $176,377,000 $210,747,000 $205,036,000 $199,490,000
Long Term Debt And Capital Lease Obligation $156,268,000 $196,773,000 $195,164,000 $182,360,000
Long Term Debt $123,786,000 $164,400,000 $171,562,000 $171,907,000
Current Debt And Capital Lease Obligation $20,109,000 $13,974,000 $9,872,000 $17,130,000
Current Debt $12,734,000 $7,756,000 $5,721,000 $8,563,000
Other Current Borrowings $12,734,000 $7,756,000 $5,721,000 $8,563,000
Liabilities
Total Liabilities Net Minority Interest $389,070,000 $423,543,000 $425,555,000 $419,660,000
Total Non Current Liabilities Net Minority Interest $196,491,000 $228,276,000 $226,918,000 $210,802,000
Other Non Current Liabilities $5,160,000 $7,389,000 $4,675,000 $3,748,000
Derivative Product Liabilities $8,497,000 - - -
Non Current Deferred Liabilities $26,566,000 $24,114,000 $27,079,000 $24,694,000
Current Liabilities $192,579,000 $195,267,000 $198,637,000 $208,858,000
Other Current Liabilities $6,129,000 $6,311,000 $5,349,000 $7,034,000
Current Deferred Liabilities $94,503,000 $85,637,000 $92,962,000 $100,665,000
Payables And Accrued Expenses $53,684,000 $66,138,000 $63,297,000 $49,871,000
Interest Payable $967,000 $485,000 $453,000 -
Payables $47,414,000 $56,274,000 $47,348,000 $39,559,000
Total Tax Payable $13,381,000 $6,254,000 $13,609,000 $8,222,000
Income Tax Payable $973,000 $1,206,000 $900,000 -
Accounts Payable $34,033,000 $50,020,000 $33,739,000 $31,337,000
Equity
Common Stock Equity $81,169,000 $45,084,000 $53,659,000 $53,189,000
Total Equity Gross Minority Interest $81,169,000 $45,084,000 $53,659,000 $53,189,000
Stockholders Equity $81,169,000 $45,084,000 $53,659,000 $53,189,000
Gains Losses Not Affecting Retained Earnings $-1,837,000 $-4,222,000 $422,000 $2,406,000
Other Equity Adjustments $-1,837,000 $-4,222,000 $422,000 $2,406,000
Retained Earnings $-519,272,000 $-517,681,000 $-502,136,000 $-492,522,000
Long Term Equity Investment $4,612,000 $9,826,000 $15,128,000 $13,879,000
Other
Ordinary Shares Number $112,643,852 $100,194,932 $96,534,609 $93,499,500
Share Issued $103,013,384 $100,194,932 $96,534,609 $93,499,500
Tangible Book Value $23,352,000 $-12,647,000 $-4,232,000 $-4,901,000
Invested Capital $217,689,000 $217,240,000 $230,942,000 $233,659,000
Working Capital $124,886,000 $127,969,000 $139,396,000 $142,032,000
Capital Lease Obligations $39,857,000 $38,591,000 $27,753,000 $19,020,000
Total Capitalization $204,955,000 $209,484,000 $225,221,000 $225,096,000
Additional Paid In Capital $602,165,000 $566,887,000 $555,276,000 $543,211,000
Capital Stock $113,000 $100,000 $97,000 $94,000
Common Stock $113,000 $100,000 $97,000 $94,000
Non Current Deferred Revenue $26,566,000 $24,114,000 $27,079,000 $24,694,000
Long Term Capital Lease Obligation $32,482,000 $32,373,000 $23,602,000 $10,453,000
Current Deferred Revenue $94,503,000 $85,637,000 $92,962,000 $100,665,000
Current Capital Lease Obligation $7,375,000 $6,218,000 $4,151,000 $8,567,000
Pensionand Other Post Retirement Benefit Plans Current $14,573,000 $17,128,000 $23,793,000 $29,441,000
Current Provisions $3,581,000 $6,079,000 $3,364,000 $4,717,000
Current Accrued Expenses $6,270,000 $9,864,000 $15,949,000 $10,312,000
Investments And Advances $4,612,000 $9,826,000 $15,128,000 $13,879,000
Investmentsin Joint Venturesat Cost $4,612,000 $9,826,000 $15,128,000 $13,879,000
Goodwill $57,802,000 $57,672,000 $57,681,000 $57,840,000
Net PPE $61,773,000 $58,547,000 $46,779,000 $29,483,000
Accumulated Depreciation $-77,911,000 $-73,683,000 $-78,563,000 $-79,210,000
Gross PPE $139,684,000 $132,230,000 $125,342,000 $108,693,000
Leases $32,491,000 $30,994,000 $26,641,000 $26,659,000
Construction In Progress $4,641,000 $2,550,000 $13,499,000 $2,999,000
Other Properties $33,115,000 $33,773,000 $25,853,000 $16,798,000
Machinery Furniture Equipment $69,437,000 $64,913,000 $59,349,000 $62,237,000
Properties $0 $0 $0 $0
Finished Goods $77,175,000 $66,996,000 $64,736,000 $64,016,000
Raw Materials $49,001,000 $57,699,000 $62,945,000 $61,871,000
Preferred Stock - - $0 $0
Fetched: 2026-06-08
Cash Flow Statement (Annual)
Metric 2025-06-30 2024-06-30 2023-06-30 2022-06-30
Free Cash Flow
Free Cash Flow $-5,663,000 $-15,505,000 $2,858,000 $-7,117,000
Operating Activities
Operating Cash Flow $2,860,000 $-11,904,000 $15,539,000 $-2,400,000
Cash Flow From Continuing Operating Activities $2,860,000 $-11,904,000 $15,539,000 $-2,400,000
Operating Gains Losses $1,976,000 $2,260,000 $-2,425,000 $3,087,000
Investing Activities
Capital Expenditure $-8,523,000 $-3,601,000 $-12,681,000 $-4,717,000
Investing Cash Flow $-8,523,000 $-3,601,000 $-12,681,000 $-4,717,000
Cash Flow From Continuing Investing Activities $-8,523,000 $-3,601,000 $-12,681,000 $-4,717,000
Capital Expenditure Reported $-4,251,000 - - -
Financing Activities
Issuance Of Capital Stock $1,627,000 $2,247,000 $2,200,000 $3,889,000
Financing Cash Flow $-4,252,000 $-3,951,000 $-2,112,000 $-15,369,000
Cash Flow From Continuing Financing Activities $-4,252,000 $-3,951,000 $-2,112,000 $-15,369,000
Net Other Financing Charges $-13,379,000 $-198,000 $-447,000 $-258,000
Net Common Stock Issuance $1,627,000 $2,247,000 $2,200,000 $3,889,000
Common Stock Issuance $1,627,000 $2,247,000 $2,200,000 $3,889,000
Repurchase Of Capital Stock - - $0 $0
Other
Repayment Of Debt $-169,500,000 $-11,000,000 $-8,865,000 $-19,000,000
Issuance Of Debt $177,000,000 $5,000,000 $5,000,000 $0
Interest Paid Supplemental Data $9,737,000 $10,520,000 $9,847,000 $7,462,000
Income Tax Paid Supplemental Data $3,870,000 $1,749,000 $2,150,000 $1,398,000
End Cash Position $62,134,000 $70,392,000 $91,202,000 $90,154,000
Beginning Cash Position $70,392,000 $91,202,000 $90,154,000 $118,201,000
Effect Of Exchange Rate Changes $1,657,000 $-1,354,000 $302,000 $-5,561,000
Changes In Cash $-9,915,000 $-19,456,000 $746,000 $-22,486,000
Net Issuance Payments Of Debt $7,500,000 $-6,000,000 $-3,865,000 $-19,000,000
Net Long Term Debt Issuance $7,500,000 $-6,000,000 $-3,865,000 $-19,000,000
Long Term Debt Payments $-169,500,000 $-11,000,000 $-8,865,000 $-19,000,000
Long Term Debt Issuance $177,000,000 $5,000,000 $5,000,000 $0
Net PPE Purchase And Sale $-4,272,000 $-3,601,000 $-12,614,000 $-4,717,000
Purchase Of PPE $-4,272,000 $-3,601,000 $-12,614,000 $-4,717,000
Change In Working Capital $-18,202,000 $-21,908,000 $4,623,000 $-22,599,000
Change In Other Working Capital $4,053,000 $-9,380,000 $-6,394,000 $1,342,000
Change In Other Current Liabilities $620,000 $321,000 $-324,000 $-880,000
Change In Payables And Accrued Expense $-24,580,000 $859,000 $3,737,000 $18,361,000
Change In Accrued Expense $-5,906,000 $-16,506,000 $887,000 $6,685,000
Change In Payable $-18,674,000 $17,365,000 $2,850,000 $11,676,000
Change In Account Payable $-18,674,000 $17,365,000 $2,850,000 $11,676,000
Change In Prepaid Assets $-2,542,000 $6,116,000 $-4,029,000 $-6,042,000
Change In Inventory $-9,109,000 $-3,998,000 $-6,855,000 $-22,861,000
Change In Receivables $13,356,000 $-15,826,000 $18,488,000 $-12,519,000
Changes In Account Receivables $13,356,000 $-15,826,000 $18,488,000 $-12,519,000
Other Non Cash Items $2,055,000 $955,000 $926,000 $817,000
Stock Based Compensation $10,201,000 $9,484,000 $10,053,000 $10,600,000
Provisionand Write Offof Assets $-101,000 $-479,000 $2,290,000 $266,000
Asset Impairment Charge $2,216,000 $6,022,000 $4,369,000 $3,478,000
Deferred Tax $156,000 $1,402,000 $456,000 $1,785,000
Deferred Income Tax $156,000 $1,402,000 $456,000 $1,785,000
Depreciation Amortization Depletion $6,150,000 $5,905,000 $4,527,000 $5,513,000
Depreciation And Amortization $6,150,000 $5,905,000 $4,527,000 $5,513,000
Earnings Losses From Equity Investments $2,952,000 $2,260,000 $-2,290,000 $3,059,000
Gain Loss On Investment Securities $499,000 - - -
Net Income From Continuing Operations $-1,591,000 $-15,545,000 $-9,280,000 $-5,347,000
Net Intangibles Purchase And Sale - $0 $-67,000 $0
Purchase Of Intangibles - $0 $-67,000 $0
Gain Loss On Sale Of PPE - $11,000 $-135,000 $28,000
Common Stock Payments - - $0 $0
Net Short Term Debt Issuance - - $5,000,000 $-15,000,000
Short Term Debt Payments - - $0 $-15,000,000
Short Term Debt Issuance - - $5,000,000 $0
Net Business Purchase And Sale - - $0 $0
Purchase Of Business - - $0 $0
Proceeds From Stock Option Exercised - - - $3,889,000
Fetched: 2026-06-08